Epstein Barr Virus External Quality Assessment

Home - quantitative method

Epstein Barr Virus External Quality Assessment

The RIQAS Epstein Barr Virus (infectious mononucleosis) EQA programme is designed to monitor the performance of tests used to detect EBV virus antibodies. All samples are conveniently supplied liquid ready-to-use and are suitable for both quantitative and qualitative methods of analysis.

  • Liquid ready-to-use
  • 100% human serum
  • Monthly reporting (6 samples per bi-annual distribution)
  • Submit results and view reports online via RIQAS.Net
  • Suitable for both quantitative and qualitative methods of analysis

Not accredited to ISO/IEC 17043

Cat NoKit SizeFrequencyCycle StartAnalytes
RQ91536 x 1ml
(1 sample to be tested per month. Samples shipped twice per year)
Monthly reporting
(1 x 12 month cycle)
July3

Parameters

  • Anti-EBNA IgG
  • Anti-EBV VCA IgG
  • Anti-EBV VCA IgM

Please note, product availability may vary country to country.